However, due to conflicting results in studies about the increase and decrease of CYP1A2 in NAFLD, curcumin administration may benefit or exacerbate the disease, an issue that requires further investigation. The gene discussed is CYP1A2; the disease is metabolic dysfunction-associated steatotic liver disease.